Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule

Clinical trial NCT05716919 · UNKNOWN

Trial details

NCT number: NCT05716919
Sponsor: Machaon Biotherapeutics, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Malignancy Solid Tumor Fibrosis

Start date: 2023-03-09
Primary completion: 2023-12-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.